10-15 Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $2.5M | Sell |
28,537
-142,305
| -83% | -$12.5M | 0.48% | 50 |
|
|
2020
Q2 | $16.8M | Buy |
170,842
+6,242
| +4% | +$613K | 3.38% | 4 |
|
|
2020
Q1 | $12.5M | Buy |
164,600
+21,203
| +15% | +$1.62M | 2.92% | 8 |
|
|
2019
Q4 | $12.7M | Sell |
143,397
-3,001
| -2% | -$266K | 2.4% | 15 |
|
|
2019
Q3 | $11.1M | Sell |
146,398
-628
| -0.4% | -$47.6K | 2.28% | 21 |
|
|
2019
Q2 | $10.7M | Buy |
147,026
+6,656
| +5% | +$484K | 2.32% | 22 |
|
|
2019
Q1 | $11.3M | Buy |
140,370
+8,471
| +6% | +$683K | 2.43% | 18 |
|
|
2018
Q4 | $12.2M | Buy |
131,899
+6,337
| +5% | +$584K | 2.98% | 10 |
|
|
2018
Q3 | $11.9M | Buy |
125,562
+6,593
| +6% | +$624K | 2.66% | 12 |
|
|
2018
Q2 | $11M | Buy |
118,969
+98,993
| +496% | +$9.17M | 2.48% | 17 |
|
|
2018
Q1 | $1.89M | Sell |
19,976
-5,144
| -20% | -$487K | 0.45% | 53 |
|
|
2017
Q4 | $2.43M | Sell |
25,120
-317
| -1% | -$30.7K | 0.58% | 45 |
|
|
2017
Q3 | $2.26M | Buy |
25,437
+132
| +0.5% | +$11.7K | 0.57% | 46 |
|
|
2017
Q2 | $1.84M | Buy |
25,305
+1,233
| +5% | +$89.4K | 0.52% | 46 |
|
|
2017
Q1 | $1.57M | Buy |
24,072
+568
| +2% | +$37K | 0.43% | 54 |
|
|
2016
Q4 | $1.47M | Buy |
23,504
+1,762
| +8% | +$110K | 0.41% | 59 |
|
|
2016
Q3 | $1.37M | Buy |
21,742
+10,032
| +86% | +$633K | 0.38% | 60 |
|
|
2016
Q2 | $725K | Buy |
11,710
+6,465
| +123% | +$400K | 0.21% | 71 |
|
|
2016
Q1 | $299K | Sell |
5,245
-70
| -1% | -$3.99K | 0.09% | 88 |
|
|
2015
Q4 | $315K | Buy |
5,315
+140
| +3% | +$8.3K | 0.09% | 94 |
|
|
2015
Q3 | $281K | Sell |
5,175
-175
| -3% | -$9.5K | 0.1% | 92 |
|
|
2015
Q2 | $359K | Sell |
5,350
-200
| -4% | -$13.4K | 0.11% | 92 |
|
|
2015
Q1 | $324K | Buy |
+5,550
| New | +$324K | 0.11% | 99 |
|